Pacific Biosciences (PACB)
NASDAQ:PACB
Holding PACB?
Track your performance easily

Pacific Biosciences (PACB) Financial Statements

2,274 Followers

Pacific Biosciences Financial Overview

Pacific Biosciences's market cap is currently ―. The company's EPS TTM is $-1.138; its P/E ratio is -1.88; Pacific Biosciences is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 38.81M$ 58.36M$ 55.69M$ 47.39M$ 38.90M
Gross Profit$ 11.28M$ 9.57M$ 17.90M$ 15.55M$ 9.76M
EBIT$ -69.10M-$ -73.99M$ -66.28M$ -84.39M
EBITDA$ -57.08M-$ -68.86M$ -61.25M$ -79.71M
Net Income Common Stockholders$ -78.18M$ -82.02M$ -65.39M$ -69.83M$ -88.02M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 561.91M$ 631.42M$ 767.79M$ 830.16M$ 875.19M
Total Assets$ 1.67B$ 1.75B$ 1.90B$ 1.85B$ 1.90B
Total Debt$ 931.37M$ 933.44M$ 935.56M$ 937.64M$ 944.83M
Net Debt$ 369.45M$ 302.02M$ 167.77M$ 107.47M$ 69.63M
Total Liabilities$ 1.02B$ 1.04B$ 1.13B$ 1.21B$ 1.20B
Stockholders Equity$ 649.02M$ 701.30M$ 763.74M$ 642.00M$ 692.12M
Cash Flow-
Free Cash Flow$ -79.56M-$ -66.01M$ -44.01M$ -98.41M
Operating Cash Flow$ -75.68M$ -57.56M$ -65.18M$ -41.74M$ -94.69M
Investing Cash Flow$ -34.14M$ -66.58M$ 242.32M$ -98.59M$ -72.55M
Financing Cash Flow$ 6.55M$ -81.60M$ -781.00K$ -4.71M$ 195.99M
Currency in USD

Pacific Biosciences Earnings and Revenue History

Pacific Biosciences Debt to Assets

Pacific Biosciences Cash Flow

Pacific Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis